Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.

English

Regional settings

Entity•Capital Com UK LimitedAuthorised and regulated by the Financial Conduct Authority (FCA)

My account

Home Markets SharesGenus PLC

Trade Genus PLC - GNSgb CFD

Summary Historical Data

Trading Conditions

Spread

0.18

Long position overnight fee

Long position overnight fee

Margin. Your investment	£1,000.00
Overnight fee Charges from full value of position	-0.025295 % (-£1.01)

Trade size with leverage ~ £5,000.00

Short position overnight fee ~ £4,000.00

Go to platform

-0.025295%

Short position overnight fee

Short position overnight fee

Margin. Your investment	£1,000.00
Overnight fee Charges from full value of position	0.003377 % (£0.14)

Trade size with leverage ~ £5,000.00

Short position overnight fee ~ £4,000.00

Go to platform

0.003377%

Overnight fee time

21:00 (UTC)

Currency

GBP

Min traded quantity

Margin

Stock exchange

United Kingdom of Great Britain and Northern Ireland

Commission on trade¹

¹Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats

Prev. Close	17.86
Open	17.84
1-Year Change	-33.13%
Day's Range	17.54 - 17.9

Genus Company profile

Genus PLC (GNS) is a is a world-leading animal genetics business. Headquartered in Basingstoke, UK, it sells products produced using biotechnology to pig and cattle farmers. The business has manufacturing facilities in key locations around the world, paired with sales forces in 75 countries. The Genus share price is listed on the London Stock Exchange and included in the FTSE 250 Index. The company’s beginnings date back to 1933 when the Milk Marketing Board’s Breeding and Production Division was founded in the UK. The key breakthrough in the Genus development happened in 1999 when the business acquired ABS Global, a US-based company founded by J.R. Prentice. As of 2018, the company’s annual revenue was £470.3 million. Check the GNS share price at Capital.com.